• Michon P
  • PV 266
  • Juin 2006

1. Ahn DK, Chae JM, Choi HS, et coll. Central cyclooxygenase inhibitors reduced IL-1beta-induced hyperalgesia in temporomandibular joint of freely moving rats. Pain. 2005,117(1-2):204-213.
2. Bingham S, Beswick PJ, Bountra C, et coll. The cyclooxygenase-2 inhibitor GW406381X [2-(4-ethoxyphenyl)-3-[4-(methylsulfonyl)phenyl]-pyrazolo[1,5-b]pyridazine] is effective in animal models of neuropathic pain and central sensitization. J. Pharmacol. Exp. Ther. 2005,312(3):1161-1169.
3. Bradley LA, Kersh BC, DeBerry JJ, et coll. Lessons from fibromyalgia: abnormal pain sensitivity in knee osteoarthritis. Novartis Found Symp 2004, 260:258-270.
4. Dembo G, Park SB, Kharasch ED. Central nervous system concentrations of cyclooxygenase-2 inhibitors in humans. Anesthesiology. 2005;102(2):409-415.
5. Diaz-Reval MI, Ventura-Martinez R, Deciga-Campos M, et coll. Evidence for a central mechanism of action of S-(+)-ketoprofen. Eur. J. Pharmacol. 2004;483:241-248.
6. Garry EM, Fleetwood-Walker SM. Organizing pains. Trends Neurosci. 2004;27:292-294
7. Ghilardi JR, Svensson CI, Rogers SD, et coll. Constitutive spinal cyclooxygenase-2 participates in the initiation of tissue injury-induced hyperalgesia. J. Neurosci. 2004, 24(11):2727-2732.
8. Gottrup H, Juhl G, Kristensen AD, et coll. Chronic oral gabapentin reduces elements of central sensitization in human experimental hyperalgesia. Anesthesiology. 2004;101:1400-1408.
9. Hempenstall K, Nurmikko TJ, Johnson RW, et coll. Analgesic therapy in postherpetic neuralgia: a quantitative systematic review. PloS. Med. 2005;2(7):e164.
10. Hochberg MC, Lebwohl MG, Plevy SE, et coll. The benefit/risk profile of TNF-blocking agents: findings of a consensus panel. Semin. Arthritis Rheum. 2005;34(6):819-836.
11. Inglis JJ, Nissim A, Lees DM, et coll. The differential contribution of tumor necrosis factor to thermal and mechanical hyperalgesia during chronic inflammation. Arthritis Res. Ther. 2005;7(4):R807-R816.
12. Kanayama M, Hashimoto T, Shigenobu K, et coll. New treatment of lumbar disc herniation involving 5-hydroxytryptamine2A receptor inhibitor: a randomized controlled trial. J. Neurosurg. Spine. 2005;2(4):441-446.
13. Kidd B. Peripheral and central pain mechanisms in osteoarthritis. Dans: Brandt LS, Doherty M, Lohmander LS: Osteoarthritis. 2ème éd.; Oxford University Press. 2003, 185-189.
14. Kjaersgaard-Andersen P, Nafei A, Skov O, et coll. Codeine plus paracetamol versus paracetamol in longer-term treatment of chronic pain due to osteoarthritis of the hip. A randomized, double-blind, multi-centre study. Pain 1990;43:309-318.
15. Kosek E, Ordeberg G. Lack of pressure pain modulation by heterotopic noxious conditioning stimulation in patients with painful osteoarthritis before, but not following, surgical pain relief. Pain 2000, 88:69-78.
16. Kwon MS, Shim EJ, Seo YJ, et coll. Effect of aspirin and acetaminophen on proinflammatory cytokine-induced pain behavior in mice. Pharmacology. 2005, 74(3):152-156.
17. Lizarraga I, Chambers JP. Involvement of opioidergic and alpha2-adrenergic mechanisms in the central analgesic effects of non-steroidal anti-inflammatory drugs in sheep. Res. Vet. Sci. 2006, 80(2):194-200.
18. Lucas R, Warner TD, Vojnovic I, et coll. Cellular mechanisms of acetaminophen: role of cyclo-oxygenase, FASEB J. 2005,19(6):635-637.
19. Mazario J, Roza C, Herrero JF. The NSAID dexketoprofen trometamol is as potent as mu-opioids in the depression of wind-up and spinal cord nociceptive reflexes in normal rats, Brain Res. 1999, 816(2):512-517.
20. McMahon SB, Cafferty WBJ, Marchand F. Immune and glial cell factors as pain mediators and modulators. Exp. Neurol. 2005, 192(2):444-462.
21. McMahon SB, Jones NG. Plasticity of pain signaling: role of neurotrophic factors exemplified by acid-induced pain. J. Neurobiol. 2004,61(1):72-87.
22. Milligan ED, Twining C, Chacur M, et coll. Spinal glia and proinflammatory cytokines mediate mirror-image neuropathic pain in rats. J. Neurosci. 2003;23:1026-1040.
23. Mollenhoff A, Nolte I, Kramer S. Anti-nociceptive efficacy of carprofen, levomethadone and buprenorphine for pain relief in cats following major orthopaedic surgery, J. Vet. Med. A Physiol. Pathol. Clin. Med. 2005,52(4):186-198.
24. Naidu MU, Ramesh Kumar T, Anuradha RT,et coll. Evaluation of phenytoin in rheumatoid arthritis--an open study. Drugs Exp. Clin. Res. 1991;17:271-275.
25. Neugebauer V, Lucke T, Schaible HG. N-methyl-D-aspartate (NMDA) and non-NMDA receptor antagonists block the hyperexcitability of dorsal horn neurons during development of acute arthritis in rat's knee joint. J. Neurophysiol. 1993; 70:1365-1377.
26. Ohtori S, Takahashi K, Moriya H,et coll. TNF-alpha and TNF-alpha receptor type 1 upregulation in glia and neurons after peripheral nerve injury: studies in murine DRG and spinal cord. Spine 2004;29(10):1082-1088.
27. Ordeberg G. Characterization of joint pain in human OA. Novartis Found. Symp. 2004;260:105-115.
28. Rao UR, Naidu MU, Kumar TR, et coll. Comparison of phenytoin with auranofin and chloroquine in rheumatoid arthritis--a double blind study. J. Rheumatol. 1995, 22:1235-1240.
29. Romanelli P, Esposito V. The functional anatomy of neuropathic pain. Neurosurg. Clin. N. Am. 2004, 15:257-268.
30. Rueff A, Dray A. Sensitization of peripheral afferent fibers in the in vitro neonatal rat spinal cord-tail by bradykinin and prostaglandins. Neuroscience 1993;54(2):527-535.
31. Samad TA, Moore KA, Sapirstein A, et coll. Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 2001, 410:471-475.
32. Schaible HG, Ebersberger A, Von Banchet GS. Mechanisms of pain in arthritis. Ann. N. Y. Acad. Sci. 2002, 966:343-354.
33. Spina E, Perugi G. Antiepileptic drugs: indications other than epilepsy. Epileptic Disord. 2004, 6(2):57-75.
34. Strangman NM, Walker JM. Cannabinoid WIN 55,212-2 inhibits the activity-dependent facilitation of spinal nociceptive responses. J. Neurophysiol. 1999;82:472-477.
35. Tal M. A role for inflammation in chronic pain. Curr. Rev. Pain. 1999;3(6):440-446.
36. Veiga AP, Duarte IP, Avila MN, et coll. Prevention by celecoxib of secondary hyperalgesia induced by formalin in rats. Life Sci. 2004;75:2807-2817.
37. Wang Y, Su DM, Wang RH, et coll. Antinociceptive effects of choline against acute and inflammatory pain. Neuroscience. 2005;132(1):49-56.
38. Watkins LR, Milligan ED, Maier SF. Glial activation: a driving force for pathological pain. Trends Neurosci. 2001;24:450-455.
39. Waugh J, Perry CM. Anakinra : a review of its use in the management of rheumatoid arthritis. Bio. Drugs. 2005;19(3):189-202.
40. You HJ, Morch CD, Chen J, et coll. Differential antinociceptive effects induced by a selective cyclooxygenase-2 inhibitor (SC-236) on dorsal horn neurons and spinal withdrawal reflexes in anesthetized spinal rats. Neuroscience. 2003;121:459-472.

En poursuivant votre navigation sur ce site, vous acceptez l’utilisation de cookies pour vous proposer des services et offres adaptés à vos centres d’intérêts.X
Pour en savoir plus et paramétrer les cookies...